Silence Therapeutics Plc American Depository Share (SLN) is a publicly traded Healthcare sector company. As of September 2, 2026, SLN trades at $14.62 with a market cap of $840.94M and a P/E ratio of -32.98. SLN moved -0.98% today. Year to date, SLN is +139.68%; over the trailing twelve months it is +209.01%. Its 52-week range spans $1.97 to $17.58. Analyst consensus is buy with an average price target of $37.00. Rallies surfaces SLN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for SLN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $14.62 |
| Market Cap | $840.94M |
| P/E Ratio | -32.98 |
| EPS | $-0.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.58 |
| 52-Week Low | $1.97 |
| Volume | 81.16K |
| Avg Volume | 0 |
| Revenue (TTM) | $615.00K |
| Net Income | $-59.95M |
| Gross Margin | 85.85% |
6 analysts cover SLN: 0 strong buy, 5 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $37.00.